vaccine-development
3 stories related to this topic, newest first.
benzinga.comModerna Collaborates on Preclinical mRNA Hantavirus Vaccine in South Korea
Newsweek reported that Moderna is involved in early-stage development of an mRNA vaccine targeting hantaviruses causing hemorrhagic fever with renal syndrome. The preclinical project, announced in 2024 by Korea University’s Vaccine Innovation Center, focuses on Asian strains and…
Moderna mRNA Flu Vaccine Beats Standard Shot in Phase 3 Trial
Moderna's mRNA-based seasonal flu vaccine proved 26.6 percent more effective than a conventional flu shot in a trial of more than 40,000 adults aged 50 and older. Results from the Phase 3 study were published Wednesday in the New England Journal of Medicine. The vaccine awaits a…
Substrate placeholder — needs reviewIs There a Cure for Hantavirus? Every Treatment on the Table, From Ivermectin to Vaccines.
No antiviral or vaccine for hantavirus is approved by the FDA. Some drugs work in vitro but fail in human trials. Ivermectin and hydroxychloroquine — the two most-asked-about repurposed drugs — have zero published research against hantavirus. Here is what every candidate, includi…